Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease
Khavkin, A.I.; Zhikhareva, N.S.; Rachkova, N.S.; Babaian, M.L.; Volynets, G.V.; Khanakaeva, Z.K.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 53-56
2004
ISSN/ISBN: 1682-8658 PMID: 15462323 Document Number: 570973
Document emailed within 1 workday
Related Documents
Danzig, J.; Navarro, R.; Inami, D.; Morreale, A.; Tokayer, A.; Wong, W.; Compton, J.; Page, R.N.; Sweet, F.B. 2001: The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion Managed Care Interface Suppl B: 13-20; Discussion 24-7 31-3Corsini, L.; Williams, L.A. 2011: Proton pump inhibitors homogenous suspensions: a compounding solution to pediatric gastroesophageal reflux disease International Journal of Pharmaceutical Compounding 15(2): 124-128
Bossuyt, P.M.M. 2005: Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics Nederlands Tijdschrift Voor Geneeskunde 149(6): 321
Numans, M.E.; Lau, J.; de Wit, N.J.; Bonis, P.A. 2004: Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics Nederlands Tijdschrift Voor Geneeskunde 148(39): 1924-1928
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Vasil'ev, I.V.; Noskova, K.K.; Zelenikin, S.A. 2002: Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage) Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 55-60; 190
Ivanova, N.G. 2002: Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 35-36; 101
Fan, Y.-H.; Lü, B.; Zhan, L.-X.; Zhang, L. 2007: Oesophageal acid exposure test in non-erosive gastroesophageal reflux disease and the diagnostic value of rabeprazole Zhonghua Nei Ke Za Zhi 46(6): 475-477
Minushkin, O.N.; Maslovskiĭ, L.V.; Anikina, N.I.; Shuleshova, A.G. 2005: Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1 Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 29-35
Orlando, R.C. 1996: Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective American Journal of Gastroenterology 91(9): 1692-1696
Yasuda, S.; Higashi, S.; Murakami, M.; Tomono, Y.; Kawaguchi, M. 1999: Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 37(5): 249-253
Pongprasobchai, S.; Kridkratoke, S.; Nopmaneejumruslers, C. 2009: Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis Journal of the Medical Association of Thailand 92(5): 632-637
Triadafilopoulos, G.; Sharma, R. 1997: Features of symptomatic gastroesophageal reflux disease in elderly patients American Journal of Gastroenterology 92(11): 2007-2011
Ding, Z-lu.; Wang, G-li.; Ji, W-jing.; Xu, X-wei. 2010: Diagnostic value of reflux disease questionnaires in children with gastroesophageal reflux disease Zhonghua Yi Xue Za Zhi 90(34): 2396-2398
Mazure, P.A. 1996: Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA) Acta Gastroenterologica Latinoamericana 26(4): 263-265
Lundell, L. 2004: Are the proton pump inhibitors all the same? Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 126-128
Creutzfeldt, W. 1994: Are proton pump inhibitors safe? Der Internist 35(12): 1137-1146
Doweck, J. 2009: Adverse effects of proton pump inhibitors Acta Gastroenterologica Latinoamericana 39(3): 219-222
Reinberg, O. 2015: Proton pump inhibitors (PPI): may be not as harmless as believed Revue Medicale Suisse 11(485): 1665-1671
Reinberg, O. 2016: Proton pump inhibitors: not as harmless as believed La Revue du Praticien 66(4): 358-360